Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Basal insulin and cardiovascular and other outcomes.

Leow MK.

N Engl J Med. 2012 Nov;367(18):1763; author reply 1763-4. doi: 10.1056/NEJMc1210553#SA4. No abstract available.

PMID:
23113497
2.

Basal insulin and cardiovascular and other outcomes.

Ceriello A.

N Engl J Med. 2012 Nov;367(18):1762-3; author reply 1763-4. doi: 10.1056/NEJMc1210553#SA3. No abstract available.

PMID:
23113496
3.

Basal insulin and cardiovascular and other outcomes.

Schernthaner G, Currie CJ.

N Engl J Med. 2012 Nov;367(18):1762; author reply 1763-4. doi: 10.1056/NEJMc1210553#SA2. No abstract available.

PMID:
23113495
4.

Basal insulin and cardiovascular and other outcomes.

Vigneri R, Vigneri P, Frittitta L.

N Engl J Med. 2012 Nov;367(18):1761-2; author reply 1763-4. doi: 10.1056/NEJMc1210553#SA1. No abstract available.

PMID:
23113494
5.

n-3 fatty acids and cardiovascular outcomes in dysglycemia.

Hurtado-Torres GF, Sandoval-Munro RL.

N Engl J Med. 2012 Nov;367(18):1760-1; author reply 1761. doi: 10.1056/NEJMc1210552#SA2. No abstract available.

PMID:
23113492
6.

n-3 fatty acids and cardiovascular outcomes in dysglycemia.

Levy Y.

N Engl J Med. 2012 Nov;367(18):1760; author reply 1761. doi: 10.1056/NEJMc1210552#SA1. No abstract available.

PMID:
23113491
7.

Comments on ORIGIN trial.

Mazzucchelli C, Bordone C, Maggi D, Cordera R.

Nutr Metab Cardiovasc Dis. 2013 Aug;23(8):e33-4. doi: 10.1016/j.numecd.2013.03.002. No abstract available.

PMID:
23786822
8.

N-3 fatty acids did not reduce major cardiovascular events in patients with dysglycaemia.

Kromhout D.

Evid Based Med. 2013 Aug;18(4):e34. doi: 10.1136/eb-2012-101012. No abstract available.

PMID:
23173155
9.

Basal insulin and cardiovascular and other outcomes in dysglycemia.

ORIGIN Trial Investigators., Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858.

10.

[Early insulin therapy in type 2 diabetes?].

Birkeland KI.

Tidsskr Nor Laegeforen. 2012 Oct 16;132(19):2151-2. doi: 10.4045/tidsskr.12.0866. Norwegian. No abstract available.

11.

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

ORIGIN Trial Investigators., Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):309-18. doi: 10.1056/NEJMoa1203859.

12.

ORIGIN trial shows safety and efficacy of insulin glargine: no adverse cardiovascular outcomes after a 6.2-year follow up of early insulin use.

Lombard L, Distiller L, Aalbers J.

Cardiovasc J Afr. 2012 Jul;23(6):357-8. No abstract available.

PMID:
23091824
13.

Learning from ORIGIN.

Bloomgarden ZT.

J Diabetes. 2012 Sep;4(3):191-2. doi: 10.1111/j.1753-0407.2012.00215.x. No abstract available.

PMID:
22716648
14.

Update in endocrinology: evidence published in 2012.

Schlechte JA.

Ann Intern Med. 2013 Jun 4;158(11):821-4. doi: 10.7326/0003-4819-158-11-201306040-00106. No abstract available.

PMID:
23580066
15.

[Basal insulin has a "neutral effect" on cardiovascular events].

Overbeck P.

MMW Fortschr Med. 2012 Jun 28;154(12):24. German. No abstract available.

PMID:
22880290
16.

Is metformin more than an oral hypoglycaemic agent?

Vague P.

Diabetes Metab. 2003 Sep;29(4 Pt 2):6S5-7. Review. No abstract available.

PMID:
14502095
17.

Insulin detemir (levemir), a new long-acting insulin.

[No authors listed]

Med Lett Drugs Ther. 2006 Jul 3;48(1238):54-5.

PMID:
16841022
18.

The diabetologist/cardiologist debate: a meeting of the minds.

Mohamed F, Aalbers J.

Cardiovasc J Afr. 2012 Mar;23(2):115-7. No abstract available.

19.

Duration of first prescribed long acting insulin therapy in type 2 diabetes.

Kostev K.

Diabetes Res Clin Pract. 2012 Jul;97(1):e3. doi: 10.1016/j.diabres.2012.01.033. No abstract available.

PMID:
22349297
20.

[What has the largest study in the history of diabetology brought us?].

Rusavý Z, Lacigová S, Kvapil M.

Vnitr Lek. 2013 Mar;59(3):160-4. Review. Czech.

PMID:
23713181
Items per page

Supplemental Content

Support Center